Development of innovative nucleic acid-based treatment options to reduce cardiovascular risk: focus on dyslipidaemia
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| Development of innovative nucleic acid-based treatment options to reduce cardiovascular risk: focus on dyslipidaemia | 12/01/2026 - 12/01/2026 | France, Virtual | Website | Cardiology | European Society of Cardiology (ESC) | 1.0 European CME credits (ECMEC®) |
